Chemoinformaics analysis of alpha-Vetispirene
| Molecular Weight | 202.341 | nRot | 1 |
| Heavy Atom Molecular Weight | 180.165 | nRig | 12 |
| Exact Molecular Weight | 202.172 | nRing | 2 |
| Solubility: LogS | -4.897 | nHRing | 0 |
| Solubility: LogP | 4.6 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 39.7194 |
| nHD | 0 | BPOL | 22.0706 |
| QED | 0.543 |
| Synth | 4.849 |
| Natural Product Likeliness | 2.164 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.073 |
| Pgp-sub | 0 |
| HIA | 0.002 |
| CACO-2 | -4.449 |
| MDCK | 0.00000934 |
| BBB | 0.24 |
| PPB | 0.943047 |
| VDSS | 2.489 |
| FU | 0.056983 |
| CYP1A2-inh | 0.876 |
| CYP1A2-sub | 0.661 |
| CYP2c19-inh | 0.783 |
| CYP2c19-sub | 0.884 |
| CYP2c9-inh | 0.526 |
| CYP2c9-sub | 0.726 |
| CYP2d6-inh | 0.577 |
| CYP2d6-sub | 0.743 |
| CYP3a4-inh | 0.429 |
| CYP3a4-sub | 0.331 |
| CL | 11.782 |
| T12 | 0.213 |
| hERG | 0.085 |
| Ames | 0.006 |
| ROA | 0.089 |
| SkinSen | 0.945 |
| Carcinogencity | 0.357 |
| EI | 0.829 |
| Respiratory | 0.729 |
| NR-Aromatase | 0.438 |
| Antiviral | Yes |
| Prediction | 0.824764 |